GPT and autosomal dominant polycystic kidney disease: Conversely, when the contribution of lixivaptan-induced ROS formation was turned off in the simulation, no ALT elevations were seen at the simulated 400 mg BID dose or at the 800/400 mg dose, i.e. doses 4 times higher than the proposed maximum clinical dose for ADPKD.